Psyence Biomedical (NASDAQ:PBM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Psyence Biomedical (PBM) operate in?

Psyence Biomedical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Psyence Biomedical Stock (NASDAQ: PBM) stock price, news, charts, stock research, profile.

Open	$0.04
Close	$0.05
Volume / Avg.	7.26M / 7.27M
Day Range	$0.04 - $0.05
52 Wk Range	0.04 - 4.31
Market Cap	$2.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	1.36%
Days to Cover	1

Recent News

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards

Psyence Biomed secures Nasdaq extension to meet compliance by December 31, advancing psilocybin-based therapeutics for mental health treatments.

Juan Spínelli

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Juan Spínelli

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.04
Close	$0.05
Volume / Avg.	7.26M / 7.27M
Day Range	$0.04 - $0.05
52 Wk Range	0.04 - 4.31
Market Cap	$2.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	1.36%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Psyence Biomedical (PBM) stock?

You can purchase shares of Psyence Biomedical (NASDAQ:PBM) through any online brokerage.

View our list of the best stock brokerages

Who are Psyence Biomedical (PBM) competitors?

Other companies in Psyence Biomedical’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).

What is the forecast, or price target, for Psyence Biomedical (PBM) stock?

There is no analysis for Psyence Biomedical to provide a consensus price target.

What is the current price for Psyence Biomedical (PBM)?

The stock price for Psyence Biomedical (NASDAQ: PBM) is $0.045 last updated November 25, 2024 at 7:49 PM EST.

Does Psyence Biomedical (PBM) pay a dividend?

There are no upcoming dividends for Psyence Biomedical.

When is Psyence Biomedical (NASDAQ:PBM) reporting earnings?

Psyence Biomedical’s Q4 earnings are confirmed for Sunday, February 2, 2025.

Is Psyence Biomedical (PBM) going to split?

There is no upcoming split for Psyence Biomedical.

What sector and industry does Psyence Biomedical (PBM) operate in?

Psyence Biomedical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Psyence Biomedical

Psyence Biomedical (PBM) Forecast